Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 5 (2008), Issue 2 (February)

1. Issues in co-morbid severe mental illnesses in HIV infected individuals.
   Int Rev Psychiatry, 20(1): 95-101. [Abstract] [Full-text]
2. Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains.
   Neurosci Res, 60(2): 184-91. [Abstract] [Full-text]
3. Metabolic alterations in medication-free patients with bipolar disorder: A 3T CSF-corrected magnetic resonance spectroscopic imaging study.
   Psychiatry Res, 162(2): 113-21. [Abstract] [Full-text]
4. Anatomical abnormalities of the anterior cingulate and paracingulate cortex in patients with bipolar I disorder.
   Psychiatry Res, 162(2): 123-32. [Abstract] [Full-text]
5. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene.
   Arch Gen Psychiatry, 65(2): 190-200. [Abstract] [Full-text]
6. Reliability of post-mortem psychiatric diagnosis for neuroscience research.
   Aust N Z J Psychiatry, 42(3): 221-7. [Abstract] [Full-text]
7. Oxcarbazepine in the maintenance treatment of bipolar disorder.
   Cochrane Database Syst Rev, 1: CD005171. [Abstract] [Full-text]
8. Antiglucocorticoid treatments for mood disorders.
   Cochrane Database Syst Rev. [Abstract] [Full-text]
9. Brain creatine kinase activity in an animal model of mania.
   Life Sci, 82(7): 424-9. [Abstract] [Full-text]
10. The relationship between childhood abuse and dissociation. Is it influenced by catechol-O-methyltransferase (COMT) activity?
    Int J Neuropsychopharmacol, 11(2): 149-61. [Abstract] [Full-text]
11. Decreased mRNA expression of netrin-g1 and netrin-g2 in the temporal lobe in schizophrenia and bipolar disorder.
    Neuropsychopharmacology, 33(4): 933-45. [Abstract] [Full-text]
12. A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?
    Int J Neuropsychopharmacol, 11(2): 269-87. [Abstract] [Full-text]
13. Hyperactive intracellular calcium dynamics in B lymphoblasts from patients with bipolar I disorder.
    Int J Neuropsychopharmacol, 11(2): 185-96. [Abstract] [Full-text]
14. The effects of pentazocine, a kappa agonist, in patients with mania.
    Int J Neuropsychopharmacol, 11(2): 243-7. [Abstract] [Full-text]
15. Risk for mania and positive emotional responding: too much of a good thing?
    Emotion, 8(1): 23-33. [Abstract] [Full-text]
16. A multimethod investigation of the behavioral activation system in bipolar disorder.
    J Abnorm Psychol, 117(1): 164-70. [Abstract] [Full-text]
17. Cognitive responses to failure and success relate uniquely to bipolar depression versus mania.
    J Abnorm Psychol, 117(1): 154-63. [Abstract] [Full-text]
18. Observed emotional involvement and overinvolvement in families of patients with bipolar disorder.
    J Fam Psychol, 22(1): 71-9. [Abstract] [Full-text]
19. Covariance component models for multivariate binary traits in family data analysis.
    Stat Med, 27(7): 1086-105. [Abstract] [Full-text]
20. Attitudes of young people towards depression and mania.
    Psychol Psychother, 81: 15-31. [Abstract] [Full-text]
21. The prevalence of mixed episodes during the course of illness in bipolar disorder.
    Acta Psychiatr Scand, 117(3): 216-24. [Abstract] [Full-text]
22. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder.
    Bipolar Disord, 10(2): 342-8. [Abstract] [Full-text]
23. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials.
    Bipolar Disord, 10(2): 323-33. [Abstract] [Full-text]
24. Behavioral Approach System and Behavioral Inhibition System sensitivities and bipolar spectrum disorders: prospective prediction of bipolar mood episodes.
    Bipolar Disord, 10(2): 310-22. [Abstract] [Full-text]
25. Influence of mood state on capacity to consent to research in patients with bipolar disorder.
    Bipolar Disord, 10(2): 303-9. [Abstract] [Full-text]
26. Effects of trauma on bipolar disorder: the mediational role of interpersonal difficulties and alcohol dependence.
    Bipolar Disord, 10(2): 293-302. [Abstract] [Full-text]
27. Predictors of trait aggression in bipolar disorder.
    Bipolar Disord, 10(2): 285-92. [Abstract] [Full-text]
28. Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders.
    Bipolar Disord, 10(2): 266-70. [Abstract] [Full-text]
29. Circadian activity rhythm abnormalities in ill and recovered bipolar I disorder patients.
    Bipolar Disord, 10(2): 256-65. [Abstract] [Full-text]
30. Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction.
    Bipolar Disord, 10(2): 245-55. [Abstract] [Full-text]
31. Clinical predictors of unrecognized bipolar I and II disorders.
    Bipolar Disord, 10(2): 238-44. [Abstract] [Full-text]
32. What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?
    Bipolar Disord, 10(2): 231-7. [Abstract] [Full-text]
33. Modulation of human motor cortex excitability by quetiapine.
    Psychopharmacology (Berl), 196(4): 623-629. [Abstract] [Full-text]
34. CBCL-pediatric bipolar disorder phenotype: severe ADHD or bipolar disorder?
    J Neural Transm, 115(2): 155-61. [Abstract] [Full-text]
35. Deciphering the lithium transcriptome: Microarray profiling of lithium-modulated gene expression in human neuronal cells.
    Neuroscience, 151(4): 1184-1197. [Abstract] [Full-text]
36. Omega-3 fatty acid deficiency augments amphetamine-induced behavioral sensitization in adult mice: prevention by chronic lithium treatment.
    J Psychiatr Res, 42(6): 458-68. [Abstract] [Full-text]
37. Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: a pilot study.
    J Psychiatr Res, 42(6): 451-7. [Abstract] [Full-text]
38. Nutritional therapies for mental disorders.
    Nutr J, 7: 2. [Abstract] [Full-text]
39. Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania.
    J Psychiatr Res, 42(5): 416-21. [Abstract] [Full-text]
40. Predictors of dropout from group therapy among patients with bipolar and substance use disorders.
    Drug Alcohol Depend, 94(1): 272-5. [Abstract] [Full-text]
41. Dysregulation of glutamate carboxypeptidase II in psychiatric disease.
    Schizophr Res, 99(1): 324-32. [Abstract] [Full-text]
42. Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: A cross-sectional assessment of a primary health care database.
    Eur Psychiatry, 23(2): 100-8. [Abstract] [Full-text]
43. Factors associated with treatment nonadherence among US bipolar disorder patients.
    Hum Psychopharmacol, 23(2): 95-105. [Abstract] [Full-text]
44. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.
    Hum Psychopharmacol, 23(2): 87-94. [Abstract] [Full-text]
45. Frontiers between attention deficit hyperactivity disorder and bipolar disorder.
    Child Adolesc Psychiatr Clin N Am, 17(2): 325-46, viii-ix. [Abstract] [Full-text]
46. Factors affecting agreement between severely mentally ill alcohol abusers' and collaterals' reports of alcohol and other substance abuse.
    Psychol Addict Behav, 22(1): 78-87. [Abstract] [Full-text]
47. Experience of subjective symptoms in euthymic patients with bipolar disorder.
    J Korean Med Sci, 23(1): 18-23. [Abstract] [Full-text]
48. The link between neurosteroids and syndromic/syndromal components of the mood spectrum disorders in women during the premenstrual phase.
    Clin Pract Epidemol Ment Health, 4(1): 3. [Abstract] [Full-text]
49. Cognitive functions in euthymic state of bipolar disorder: An Indian study.
    Cognit Neuropsychiatry, 13(2): 135-47. [Abstract] [Full-text]
50. Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients.
    Int Clin Psychopharmacol, 23(2): 88-94. [Abstract] [Full-text]
51. Research with severely mentally ill latinas: successful recruitment and retention strategies.
    J Immigr Minor Health, 10(2): 145-53. [Abstract] [Full-text]
52. Divergent backward masking performance in schizophrenia and bipolar disorder: association with COMT.
    Am J Med Genet B Neuropsychiatr Genet, 147(2): 223-7. [Abstract] [Full-text]
53. Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism.
    Am J Med Genet B Neuropsychiatr Genet, 147(2): 134-66. [Abstract] [Full-text]
54. Pediatric Bipolar Disorder.
    Annu Rev Clin Psychol. [Abstract] [Full-text]
55. Association between GSK-3beta -50T/C polymorphism and personality and psychotic symptoms in mood disorders.
    Psychiatry Res, 158(2): 132-140. [Abstract] [Full-text]
56. Association of the brain-derived neurotrophic factor gene and bipolar disorder with early age of onset in mainland China.
    Neurosci Lett, 433(2): 98-102. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.